Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XELOX vs FOLFOX in Advanced Gastric Cancer
NCT01748851Phase 3Terminated
- Start
- Dec 2012
- Primary completion
- Sep 2014
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in gastric cancer (GC). Started Dec 2012; status: terminated.
02
Drugs
capecitabine
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT01748851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01748851.